To say that Ozempic is a blockbuster drug is an understatement. Producer Novo Nordisk is scrambling to develop manufacturing websites to maintain up with international demand.
Whereas Ozempic is simply authorized for the therapy of diabetes in Australia, it’s also marketed abroad for weight reduction beneath the model title Wegovy.
Social media is filled with posts and endorsements by celebrities who’re utilizing it for weight reduction. Confronted with restricted entry in Australia, some individuals who want the remedy for diabetes can’t entry it.
Others are turning to the web to supply it from compounding pharmacies — a observe Australia’s regulator, the Therapeutic Items Administration (TGA), plans to clamp down on.
How docs are prescribing Ozempic
Use of Ozempic for weight reduction in Australia is taken into account “off label”. That is when a health care provider prescribes a drugs for a function outdoors of what’s authorized.
Ozempic is simply authorized for use for the therapy of diabetes in Australia, however its off-label prescribing for weight reduction is
To handle these shortages, Australian docs and pharmacies are being requested on Ozempic and to prioritise it for sufferers with kind 2 diabetes who’re already stabilised on this drugs.
Nevertheless, the TGA says it “doesn’t have the ability to manage the medical selections of well being professionals and is unable to stop docs from utilizing their medical judgement to prescribe Ozempic for different well being circumstances.”
Why can’t we simply make extra Ozempic?
The energetic ingredient in Ozempic, semaglutide, is a fragile peptide molecule made up of two small chains of amino acids. It’s only one in a household of medication which might be categorized as GLP-1 inhibitors.
As a result of it’s a peptide, its manufacture is complicated and requires specialised amenities past these used to make regular chemical-based medication.
It’s also delivered by way of an injection, which means that it must be manufactured beneath strict circumstances to make sure it’s each sterile and temperature-controlled.
This implies rising manufacturing shouldn’t be so simple as simply deciding to fabricate extra. Its producer wants time to construct new amenities to extend manufacturing.
Compounding pharmacies are making their very own
Compounding is the observe of mixing, mixing, or altering components of a drug to create a formulation tailor-made to the wants of a person affected person.
Australian legislation permits pharmacists to compound solely when it’s for the therapy of a specific affected person to satisfy their particular person medical want and there’s no appropriate commercially manufactured product obtainable. An instance is making a liquid type of a drug from a pill for folks unable to swallow.
Compounded merchandise aren’t held to the identical security, high quality and efficacy requirements required for mass produced medicines. This recognises the one-off nature of such compounded medicines and the skilled coaching of the pharmacists who put together them.
Not too long ago, pharmacies have been counting on these compounding guidelines to supply their very own Ozempic-like merchandise at scale and ship them to shoppers round Australia.
Nevertheless, there are dangers when utilizing these merchandise. The US Meals and Drug Administration (FDA) has just lately warned shoppers of the hazards of utilizing compounded formulations that comprise explicit salt formulations of semaglutide. It has acquired extra stories of unwanted effects in sufferers utilizing these merchandise.
How the regulator plans to tighten the loophole
The TGA is taking a variety of steps to tighten the compounding loophole and there are ongoing investigations on this space.
In December 2023, the company issued a on the hazards of those compounded medicines.
Extra just lately, it has proposed eradicating GLP-1 medication, which incorporates Ozempic, from Australia’s compounding exemptions. This might successfully ban pharmacies from making off-brand Ozempic. This proposal is at the moment beneath session and a remaining resolution is anticipated by June this 12 months.
If you wish to entry the drug for weight reduction earlier than the scarcity is over, bear in mind that compounded merchandise aren’t an identical to authorized Ozempic and haven’t been evaluated for security, high quality and efficacy.
Provide of copycat variations can also be more likely to be restricted, given the continued TGA crackdown.
Jessica Tempo is Affiliate Lecturer, Sydney Pharmacy College on the College of Sydney.
Andrew Bartlett is Affiliate Lecturer Pharmacy Follow on the College of Sydney. He’s a member of the
Pharmaceutical Society of Australia.
Nial Wheate is Affiliate Professor of the College of Pharmacy on the College of Sydney.
He has up to now acquired funding from the ACT Most cancers Council, Tenovus Scotland, Medical Analysis Scotland, Scottish Crucible, and the Scottish Universities Life Sciences Alliance. He’s a Fellow of the Royal Australian Chemical Institute, a member of the Australasian Pharmaceutical Science Affiliation, and a member of the Australian Institute of Firm Administrators. Nial is the chief scientific officer of Vaihea Skincare LLC, a director of SetDose Pty Ltd a medical system firm, and a Requirements Australia panel member for sunscreen brokers. Nial often consults to trade on points to do with drugs threat assessments, manufacturing, design, and testing.
<br>
